"オミクロンXBB.1.5-適応型COVID-19ワクチンの比較効果:体系的な文献レビューとネットワークメタ解析"への返信
Kyle Fahrbach1, Allie Cichewicz1, Haitao Chu2
1Evidera Inc, Wilmington, NC, USA.
Expert review of vaccines
|August 29, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.9K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
2.0K
関連する概念動画
Cross-reactivity
31.5K
Overview
31.5K
Vaccinations
45.3K
Overview
45.3K
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Humoral Immune Responses
75.7K
Overview
75.7K
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
